COZART EIA OPIATES ORAL FLUID KIT— 510(k) K024339

Name: FDA 510(k) clearance K024339
Creator: U.S. Food and Drug Administration
Published: 2003-04-07

Substantially Equivalent

Cozart Bioscience , Ltd.

FDA 510(k) clearance K024339 for COZART EIA OPIATES ORAL FLUID KIT, Substantially Equivalent on 2003-04-07. Applicant: Cozart Bioscience , Ltd.. Device class: 1.

Clearance details

Applicant: Cozart Bioscience , Ltd.
Product code: Code DIG
Device class: Class 1
Regulation: 21 CFR 862.3240
Advisory panel: Clinical Toxicology
Date received: 2002-12-27
Decision date: 2003-04-07
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Oxfordshire Ox14 4ru, GB

Download summary PDF View on FDA.gov ↗

More clearances from Cozart Bioscience , Ltd.

view all

K033743 — COZART EIA AMPHETAMINES ORAL FLUID MICROPLATE KIT2004-06-03
K021944 — COZART EIA COTININE URINE KIT2003-05-14
K030234 — COZART EIA COCAINE ORAL FLIUD KIT2003-04-28
K020920 — COZART RAPISCAN ORAL FLUID DRUG TEST - OPIATE/METHADONE2002-11-05
K011131 — METHADONE MICROPLATE EIA URINE APPLICATION2001-07-31

Data sourced from openFDA. This site is unofficial and independent of the FDA.